Similar articles

Abstract: Microorganisms provide both beneficial and harmful effects to human beings. Beneficial effects come from the symbiotic relationship that exists between humans and microbiota, but then several human illnesses have turned some friendly microbes into opportunistic pathogens, causing several microbial-related diseases. Various efforts have been made to create and utilize antimicrobial agents in the treatment and prevention of these infections, but such efforts have been hampered by the emergence of antimicrobial resistance. Despite extensive studies on drug discovery to alleviate this problem, issues with the toxicity and tolerance of certain compounds and continuous microbial evolution have forced researchers to focus on screening various phytochemical dietary compounds for antimicrobial activity. linolenic acid and its derivatives (eicosapentaenoic acid and docosahexaenoic acid) are fatty acid%29&ck%5B%5D=abstract&ck%5B%5D=keyword'>omega-3 fatty acids that have been studied due to their role in human health, being important for the brain, the eye, the cardiovascular system, and general human growth. However, their utilization as antimicrobial agents has not been widely appreciated, perhaps due to a lack of understanding of antimicrobial mechanisms, toxicity, and route of administration. Therefore, this review focuses on the efficacy, mechanism, and toxicity of fatty acid%29&ck%5B%5D=abstract&ck%5B%5D=keyword'>omega-3 fatty acids as alternative therapeutic agents for treating and preventing diseases associated with pathogenic microorganisms.

Omega-3不饱和脂肪酸对病原微生物的影响

[1]Albonetti S, Minardi P, Trombetti F, et al., 2017. In vivo and in vitro effects of selected antioxidants on rabbit meat microbiota. Meat Sci, 123:88-96.

[2]Arterburn LM, Oken HA, Hoffman JP, et al., 2007. Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food. Lipids, 42(11):1011-1024.

[3]Babajide JM, Olaluwoye AA, Taofik Shittu TA, et al., 2013. Physicochemical properties and phytochemical components of spiced cucumber-pineapple fruit drink. Niger Food J, 31(1):40-52.

[4]Bordi C, de Bentzmann S, 2011. Hacking into bacterial biofilms: a new therapeutic challenge. Ann Intensive Care, 1:19.

[5]Burlingame B, Nishida C, Uauy R, et al., 2009. Fats and fatty acids in human nutrition: introduction. Ann Nutr Metab, 55(1-3):5-7.

[6]Calder PC, 2006. N3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr, 83(6):S1505-S1519.

[7]Calo JR, Crandall PG, O'Bryan CA, et al., 2015. Essential oils as antimicrobials in food systems—a review. Food Control, 54:111-119.

[8]Calviello G, Palozza P, Franceschelli P, et al., 1997. Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues. Lipids, 32(10):1075-1083.

[9]Carballeira NM, 2008. New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents. Prog Lipid Res, 47(1):50-61.

[10]Casos K, Zaragoza MC, Zarkovic N, et al., 2010. A fish-oil-rich diet reduces vascular oxidative stress in apoE^−/− mice. Free Radic Res, 44(7):821-829.

[11]Cavalieri SJ, Rankin ID, Harbeck RJ, et al., 2005. Antimicrobial modes of action. In: Coyle MB (Ed.), Manual of Antimicrobial Susceptibility Testing. American Society for Microbiology, Washington DC, p.3-14.

[12]CDC (Centers for Disease Control and Prevention), 2015. Antimicrobial Resistance. http://www.cdc.gov/drugresistance/about.html [Accessed on Oct. 17, 2016].

[13]Cheng CL, Huang SJ, Wu CL, et al., 2015. Transgenic expression of omega-3 PUFA synthesis genes improves zebrafish survival during Vibrio vulnificus infection. J Biomed Sci, 22(1):103.

[14]Collins ML, Lynch B, Barfield W, et al., 2014. Genetic and acute toxicological evaluation of an algal oil containing eicosapentaenoic acid (EPA) and palmitoleic acid. Food Chem Toxicol, 72:162-168.

[15]Correia M, Michel V, Matos AA, et al., 2012. Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. PLoS ONE, 7(4): e35072.

[16]Das UN, 2008. Can essential fatty acids reduce the burden of disease(s)? Lipids Health Dis, 7(1):9.

[17]Desbois AP, 2012. Potential applications of antimicrobial fatty acids in medicine, agriculture and other industries. Recent Pat Antiinfect Drug Discov, 7(2):111-122.

[18]Desbois AP, 2013. Antimicrobial properties of eicosapentaenoic acid (C20:5n−3). In: Kim SK (Ed.), Marine Microbiology. Wiley Online Library, p.351-367.

[19]Desbois AP, Smith VJ, 2010. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol, 85(6):1629-1642.

[20]Desbois AP, Lawlor KC, 2013. Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus. Marine Drugs, 11(11):4544-4557.

[21]di Nunzio M, Valli V, Bordoni A, 2011. Pro- and anti-oxidant effects of polyunsaturated fatty acid supplementation in HepG2 cells. Prostag Leukotr Ess, 85(3-4):121-127.

[22]El-Sharkawy H, Aboelsaad N, Eliwa M, et al., 2010. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 fatty acids and low-dose aspirin. J Periodontol, 81(11):1635-1643.

[23]Frieri G, Pimpo MT, Palombieri A, et al., 2000. Polyunsaturated fatty acid dietary supplementation: an adjuvant approach to treatment of Helicobacter pylori infection. Nutr Res, 20(7):907-916.

[24]Fung DYC, Sheree Lin CC, Gailani MB, 1985. Effect of phenolic antioxidants on microbial growth. CRC Crit Rev Microbiol, 12(2):153-183.

[25]Grundt H, Nilsen DWT, Mansoor MA, et al., 2003. Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. Eur J Clin Nutr, 57(6):793-800.

[26]Hilmarsson H, Traustason BS, Kristmundsdottir T, et al., 2007. Virucidal activities of medium- and long-chain fatty alcohols and lipids against respiratory syncytial virus and parainfluenza virus type 2: comparison at different pH levels. Arch Virol, 152(12):2225-2236.

[27]Hoffman DR, 2013. What are EPA/DHA? http://drhoffman.com/wp-content/plugins/post2pdf-converter/post2pdf-converter-pdf-maker.php?id=2513 [Accessed on Aug. 30, 2016].

[28]Huang C, 2011. Omega polyunsaturated fatty acids for the treatment of oral diseases. http://www.google.com/patents/WO2011056327A1?cl=en [Accessed on Jan. 3, 2017].

[29]Huang CB, Ebersole JL, 2010. A novel bioactivity of omega-3 polyunsaturated fatty acids and their ester derivatives. Mol Oral Microbiol, 25(1):75-80.

[30]Igennus, 2016. EPA vs DHA—understand the difference. https://igennus.com/nutrition/omega-3-science/epa-vs-dha/# [Accessed on Jan. 3, 2017].

[31]Jackman JA, Yoon BK, Li D, et al., 2016. Nanotechnology formulations for antibacterial free fatty acids and monoglycerides. Molecules, 21(3):305.

[32]Jung SW, Lee SW, 2016. The antibacterial effect of fatty acids on Helicobacter pylori infection. Korean J Intern Med, 31(1):30-35.

[33]Kabara JJ, 1979. Toxicological, bacteriocidal and fungicidal properties of fatty acids and some derivatives. J Am Oil Chem Soc, 56(11):760A-767A.

[34]Kalia M, Yadav VK, Singh PK, et al., 2015. Effect of cinnamon oil on quorum sensing-controlled virulence factors and biofilm formation in Pseudomonas aeruginosa. PLoS ONE, 10(8):e0135495.

[35]Kroes R, Schaefer EJ, Squire RA, et al., 2003. A review of the safety of DHA45-oil. Food Chem Toxicol, 41(11):1433-1446.

[36]Lawrence GD, 2010. The Fats of Life: Essential Fatty Acids in Health and Disease. Rutgers University Press, p.11-43.

[37]Leekha S, Terrell CL, Edson RS, 2011. General principles of antimicrobial therapy. Mayo Clin Proc, 86(2):156-167.

[38]Lopez-Romero JC, Gonzalez-Rios H, Borges A, et al., 2015. Antibacterial effects and mode of action of selected essential oils components against Escherichia coli and Staphylococcus aureus. Evid-Based Compl Altern Med, 2015:795435.

[39]Matouk E, 2014. Safety study of fenretinide in adult patients with cystic fibrosis. https://clinicaltrials.gov/ct2/show/ NCT02141958?term=Docosahexaenoic&phase=0467%20&rank=20 [Accessed on Jan. 3, 2017].

[40]Mattos GN, Tonon RV, Furtado AA, et al., 2016. Grape by-products extracts against microbial proliferation and lipid oxidation: a review. J Sci Food Agric, 97(4):1055-1064.

[41]Mil-Homens D, Bernardes N, Fialho AM, et al., 2012. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia. FEMS Microbiol Lett, 328(1): 61-69.

[42]Mileski KS, Ciric AD, Trifunovic SS, et al., 2016. Heracleum orphanidis: chemical characterisation, and comparative evaluation of antioxidant and antimicrobial activities with specific interest in the influence on Pseudomonas aeruginosa PAO1. Food Funct, 7(9):4061-4074.

[43]Morais-Braga MF, Souza TM, Santos KK, et al., 2012. Phenolic compounds and interaction between aminoglycosides and natural products of Lygodium venustum SW against multiresistant bacteria. Chemotherapy, 58(5):337-340.

[44]Moss JWE, Ramji DP, 2016. Nutraceutical therapies for atherosclerosis. Nat Rev Cardiol, 13(9):513-532.

[45]Mukherjee PK, Nema NK, Maity N, et al., 2013. Phytochemical and therapeutic potential of cucumber. Fitoterapia, 84:227-236.

[46]Nascimento GGF, Locatelli J, Freitas PC, et al., 2000. Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria. Braz J Microbiol, 31:247-256.

[47]Neitzel JJ, 2010. Fatty acid molecules: fundamentals and role in signaling. Nat Educ, 3(9):57.

[48]Oh DY, Talukdar S, Bae EJ, et al., 2010. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell, 142(5):687-698.

[49]Olveira G, Olveira C, Acosta E, et al., 2010. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis. Arch Bronconeumol, 46(2):70-77.

[50]Page RC, 1991. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res, 26(3):230-242.

[51]Pagliaro B, Santolamazza C, Simonelli F, et al., 2015. Phytochemical compounds and protection from cardiovascular diseases: a state of the art. Biomed Res Int, 2015:918069.

[52]Prince AS, 2002. Biofilms, antimicrobial resistance, and airway infection. New Engl J Med, 347(14):1110-1111.

[53]Richard D, Kefi K, Barbe U, et al., 2008. Polyunsaturated fatty acids as antioxidants. Pharmacol Res, 57(6):451-455.

[54]Schmitt D, Tran N, Peach J, et al., 2012. Toxicologic evaluations of DHA-rich algal oil in rats: developmental toxicity study and 3-month dietary toxicity study with an in utero exposure phase. Food Chem Toxicol, 50(11):4149-4157.

[55]Sharma G, Rao S, Bansal A, et al., 2014. Pseudomonas aeruginosa biofilm: potential therapeutic targets. Biologicals, 42(1):1-7.

[56]Shin SY, Bajpai VK, Kim HR, et al., 2007. Antibacterial activity of bioconverted eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) against foodborne pathogenic bacteria. Int J Food Microbiol, 113(2):233-236.

[57]Smith WL, 2005. Cyclooxygenases, peroxide tone and the allure of fish oil. Curr Opin Cell Biol, 17(2):174-182.

[58]Sousa AS, Prates RA, de Santi MESO, et al., 2016. Photodynamic inactivation of Candida albicans biofilm: influence of the radiant energy and photosensitizer charge. Photodiagn Photodyn, 14:111-114.

[59]Sun M, Zhou Z, Dong J, et al., 2016. Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria. Microb Pathogenesis, 99:196-203.

[60]Thormar H, 2011. Antibacterial effects of lipids: historical review (1881 to 1960). Lipids and Essent Oils as Antimicro Agents. John Wiley & Sons, Ltd., p.25-45.

[61]US FDA (Food and Drug Administration), 2004. Substances affirmed as generally recognized as safe: menhaden oil [Docket No. 1999P-5332]. US Federal Register, p.2313-2317. https://www.federalregister.gov/documents/2004/01/ 15/04-811/substances-affirmed-as-generally-recognized-as-safe-menhaden-oil [Accessed on Apr. 3, 2017].

[62]van Dyke TE, Serhan CN, 2003. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res, 82(2):82-90.

[63]Wainwright M, 1989. Moulds in ancient and more recent medicine. Mycologist, 3(1):21-23.

[64]Wall R, Ross RP, Fitzgerald GF, et al., 2010. Fatty acids from fish: the anti-inflammatory potential of long-chain ω-3 fatty acids. Nutr Rev, 68(5):280-289.

[65]WHO, 1995. WHO and FAO joint consultation: fats and oils in human nutrition. Nutr Rev, 53(7):202-205.

[66]Zhang YM, Rock CO, 2008. Membrane lipid homeostasis in bacteria. Nat Rev Microl, 6(3):222-233.

[67]Zheng CJ, Yoo JS, Lee TG, et al., 2005. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett, 579(23):5157-5162.